Congressman Donald Norcross

Representing the 1st District of New Jersey
Mobile Menu - OpenMobile Menu - Closed

Norcross’ Opioid Bills Move Forward in Senate

Sep 18, 2018
News Release
Norcross Introduced the Jobs Plus Recovery Act; Is Vice-Chair of the Bipartisan Task Force to Combat the Heroin Epidemic

CHERRY HILL, NJ – Following the Senate’s passage of legislation to help combat the opioid epidemic that included provisions Congressman Donald Norcross (NJ-01) authored and supported, Norcross applauded the progress and called for additional Congressional action.

Most notably, a version of Norcross’ bipartisan Jobs Plus Recovery Act, which includes job training in drug addiction recovery programs, moved forward.

“Every single day, at least one person in my district alone is dying from the disease of addiction, and we need to do everything we can to help the hundreds of thousands of Americans struggling,” said Congressman Donald Norcross, Vice-Chair of the Bipartisan Task Force to Combat the Heroin Epidemic. “As our loved ones work hard to recover, we should make sure they have the support they need to hold good-paying jobs and contribute to their communities. By including job training in the recovery process, we are investing in our friends, neighbors, sons and daughters when they need us most, and our economy will be stronger as a result.”

He added: “While it’s good that Congress is taking steps to help, I know that we must do more to save lives. Leaders in Congress and the Administration should advance the whole suite of bills supported by the Bipartisan Heroin Task Force because one preventable death is too many.”

The Senate-passed legislation also contained versions of bills that are part of the Bipartisan Task Force’s 2018 legislative agenda, including:

  • The Addiction Treatment Access Improvement Act, which facilitates the use of Medication Assisted Therapy (MAT) by repealing existing limits on how many patients doctors can treat with MAT.
  • The CRIB Act, which would establish residential pediatric care centers within Medicaid to treat babies with neonatal abstinence syndrome caused by exposure to opioids during pregnancy.
  • The Synthetic Drug Awareness Act, which requires a report to Congress on the public health effects of the rise in synthetic drug use among youth ages 12 to 18.

Recent, Related Content


Contact: Ally Kehoe, Communications Director